Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves Cyramza for stomach cancer

April 22, 2014Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach.

Post navigation

← Wegmans Food Markets, Inc. Issues Allergy Alert on Undeclared Egg in Wegmans Easter Bread, 17 oz. Hospira Announces Voluntary Nationwide Recall of One Lot of 0.25% Marcaine™ (Bupivacaine HCI Injection, USP), 10 ml, Single-Dose, Preservative-Free Vial Due to Visible Particulates →
Proudly powered by WordPress